Design Therapeutics, Inc. SEC filings DSGN

Design Therapeutics, Inc. has 268 filings in SEC EDGAR's recent list, going back to Mar 20, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Design Therapeutics, Inc. SEC filings
Form Description Filed Period
S-3 Shelf registration Nov 4, 2026 —
424B5 Prospectus supplement Nov 4, 2026 —
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 9, 2026 —
8-K Current report
Other events
May 18, 2026 May 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report Apr 28, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Apr 28, 2026 Apr 28, 2026
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Apr 23, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
4 Insider transaction Apr 1, 2026 Mar 31, 2026
3 Initial insider ownership Apr 1, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Apr 1, 2026 Mar 31, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 11, 2026 —
S-8 Employee stock plan registration Mar 9, 2026 —
10-K Annual report Mar 9, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 9, 2026 Mar 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Officer or director change
Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Dec 11, 2025 Dec 9, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 12, 2025 —
144 Notice of proposed sale Nov 7, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
4 Insider transaction Sep 10, 2025 Sep 9, 2025
3 Initial insider ownership Sep 10, 2025 Sep 9, 2025
8-K Current report
Officer or director change
Sep 10, 2025 Sep 9, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 28, 2025 —
4 Insider transaction Aug 14, 2025 Aug 13, 2025
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 13, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 10, 2025
4 Insider transaction May 23, 2025 May 1, 2025
3 Initial insider ownership May 23, 2025 Apr 16, 2025
EFFECT Filing May 16, 2025 —
CORRESP Letter to the SEC May 14, 2025 —
UPLOAD Letter from the SEC May 13, 2025 —
S-3 Shelf registration May 7, 2025 —
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
DEFR14A Filing Apr 30, 2025 —
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 10, 2025
S-8 Employee stock plan registration Mar 10, 2025 —
10-K Annual report Mar 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
3 Initial insider ownership Feb 7, 2025 Oct 1, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Dec 19, 2024 Dec 18, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13D/A Amended ownership over 5% (active) Aug 13, 2024 —
4 Insider transaction Aug 12, 2024 Aug 9, 2024
144 Notice of proposed sale Aug 9, 2024 —
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 17, 2024 Jun 13, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 13, 2024
4 Insider transaction Mar 25, 2024 Mar 22, 2024
4 Insider transaction Mar 25, 2024 Mar 25, 2024
3 Initial insider ownership Mar 20, 2024 Mar 13, 2024
S-8 Employee stock plan registration Mar 19, 2024 —
10-K Annual report Mar 19, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
4 Insider transaction Jan 5, 2024 Jan 2, 2024
4 Insider transaction Jan 5, 2024 Jan 2, 2024
4 Insider transaction Dec 5, 2023 Dec 1, 2023
4 Insider transaction Dec 5, 2023 Dec 1, 2023
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
4 Insider transaction Oct 2, 2023 Sep 29, 2023
SC 13G/A Amended ownership over 5% (passive) Sep 7, 2023 —
4/A Form 4/a submission Sep 6, 2023 Mar 30, 2021
4 Insider transaction Sep 5, 2023 Sep 1, 2023
4 Insider transaction Aug 30, 2023 Aug 29, 2023
4 Insider transaction Aug 30, 2023 Aug 28, 2023
8-K Current report
Officer or director change
Aug 25, 2023 Aug 25, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
4 Insider transaction Jun 2, 2023 May 31, 2023
8-K Current report
Shareholder vote results
Jun 1, 2023 May 31, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders Apr 13, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 13, 2023 —
DEF 14A Proxy statement Apr 13, 2023 May 31, 2023
SC 13G Ownership over 5% (passive) Apr 3, 2023 —
S-8 Employee stock plan registration Mar 14, 2023 —
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 14, 2023 Mar 14, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G Ownership over 5% (passive) Feb 8, 2023 —
4 Insider transaction Feb 3, 2023 Feb 1, 2023
4 Insider transaction Feb 3, 2023 Feb 1, 2023
4 Insider transaction Feb 3, 2023 Feb 1, 2023
4 Insider transaction Feb 3, 2023 Feb 1, 2023
SC 13G Ownership over 5% (passive) Feb 3, 2023 —
SC 13D/A Amended ownership over 5% (active) Dec 22, 2022 —
SC 13G Ownership over 5% (passive) Dec 22, 2022 —
4 Insider transaction Dec 21, 2022 Dec 19, 2022
4 Insider transaction Dec 20, 2022 Dec 16, 2022
4 Insider transaction Dec 20, 2022 Dec 16, 2022
4 Insider transaction Dec 12, 2022 Dec 9, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
SC 13G Ownership over 5% (passive) Oct 13, 2022 —
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 15, 2022
8-K Current report
Shareholder vote results
Jun 16, 2022 Jun 15, 2022
EFFECT Filing May 9, 2022 —
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
CORRESP Letter to the SEC May 5, 2022 —
CORRESP Letter to the SEC May 2, 2022 —
UPLOAD Letter from the SEC Apr 29, 2022 —
S-3 Shelf registration Apr 27, 2022 —
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 15, 2022
SC 13D Ownership over 5% (active) Mar 31, 2022 —
4 Insider transaction Mar 22, 2022 Mar 21, 2022
4 Insider transaction Mar 22, 2022 Mar 18, 2022
8-K Current report
Material agreement
Mar 22, 2022 Mar 18, 2022
4 Insider transaction Mar 18, 2022 Mar 16, 2022
S-8 Employee stock plan registration Mar 10, 2022 —
10-K Annual report Mar 10, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G Ownership over 5% (passive) Feb 9, 2022 —
SC 13G Ownership over 5% (passive) Feb 9, 2022 —
SC 13G Ownership over 5% (passive) Feb 9, 2022 —
4 Insider transaction Feb 2, 2022 Feb 1, 2022
4 Insider transaction Feb 2, 2022 Feb 1, 2022
4 Insider transaction Feb 2, 2022 Feb 1, 2022
4 Insider transaction Feb 2, 2022 Feb 1, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
DSGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1807120

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.